Sustainability | December 12, 2025
Dr. Reddy's Laboratories announces SBTi targets
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
The product will be marketed by Dr. Reddy's Laboratories Inc.
Acetaminophen Injection is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older
Adverse events were similar to placebo, and no AP-101-induced antibody responses were detected
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Captured microbes are then neutralized on engineered microbicidal surfaces
_Logo_256_384.png){kind=logo}
The Vital Shape panels provide tiered assessments to detect obesity-related risks early
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
Growing patent filings and tier-2 innovators reflect expanding national research base
The technology is intended to support imaging-based training, protocol optimisation and surgical planning
Subscribe To Our Newsletter & Stay Updated
